World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
42139
World Ranking
6012
National Ranking
66

Jorma Isola publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jorma Isola sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 344 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jorma Isola D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jorma Isola sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 108 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jorma Isola is affiliated with Tampere University in Finland and has contributed extensively to the field of medicine, with a concentrated focus on gastroenterology. Their body of work encompasses research in several subfields, including gastroenterology, epidemiology, oncology, radiology, nuclear medicine and imaging, and surgery.

Their research spans key topics such as celiac disease research and management, microscopic colitis, HER2/EGFR in cancer research, monoclonal and polyclonal antibodies research, digestive system and related health, genetic factors in colorectal cancer, and Helicobacter pylori-related gastroenterology studies.

Notable recent publications include:

  • A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease (2021, New England Journal of Medicine)
  • ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer (2020, Cancer Letters)
  • Genome-Wide Transcriptomic Analysis of Intestinal Mucosa in Celiac Disease Patients on a Gluten-Free Diet and Postgluten Challenge (2020, Cellular and Molecular Gastroenterology and Hepatology)
  • Deep learning identifies morphological features in breast cancer predictive of cancer ERBB2 status and trastuzumab treatment efficacy (2021, Scientific Reports)
  • Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge (2022, Gastroenterology)

Frequent co-authors collaborating with Jorma Isola include Markku Mäki, Juha Taavela, Alina Popp, Heikki Joensuu, and Keijo Viiri. These collaborations highlight a network of researchers with shared interests in related medical and gastroenterological topics.

Jorma Isola's work has been published predominantly in the following venues:

  • Gastroenterology
  • Cancer Letters
  • Scientific Reports
  • The Lancet. Gastroenterology & Hepatology
  • Digestive Diseases and Sciences

Their research contributions are situated within a strong clinical and biomedical context, addressing both disease mechanisms and therapeutic approaches. The focus on celiac disease and cancer-related antibody research ties together immune-mediated and oncological pathways. The use of transcriptomic analyses and advanced imaging reflects an integration of molecular and clinical methodologies to understand disease at multiple levels.

Best Publications

  • In vivo amplification of the androgen receptor gene and progression of human prostate cancer.

    Tapio Visakorpi;Eija Hyytinen;Pasi Koivisto;Minna Tanner

  • Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.

    Heikki Joensuu;Pirkko-Liisa Kellokumpu-Lehtinen;Petri Bono;Tuomo Alanko

  • Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors.

    Olli‐P ‐P Kallioniemi;Anne Kallioniemi;Jim Piper;Jorma Isola

  • Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

    Ari Ristimäki;Anna Sivula;Johan Lundin;Mikael Lundin

  • Androgen Receptor Gene Amplification: A Possible Molecular Mechanism for Androgen Deprivation Therapy Failure in Prostate Cancer

    Pasi Koivisto;Juha Kononen;Christian Palmberg;Teuvo Tammela

  • Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

    M. Tanner;M. Hollmén;T. T. Junttila;A. I. Kapanen

  • Inherited susceptibility to uterine leiomyomas and renal cell cancer

    Virpi Launonen;Outi Vierimaa;Maija Ht Kiuru;Jorma Isola

  • Decreased Accessibility and Lack of Activation of ErbB2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line

    Peter Nagy;Elza Friedländer;Minna Tanner;Anita I. Kapanen

  • Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

    Lao H. Saal;Peter Johansson;Karolina Holm;Sofia K. Gruvberger-Saal

  • Genetic Changes in Primary and Recurrent Prostate Cancer by Comparative Genomic Hybridization

    Tapio Visakorpi;Anne H. Kallioniemi;Ann-Christine Syvänen;Eija R. Hyytinen

  • ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67

    Vilppu J Tuominen;Sanna Ruotoistenmäki;Arttu Viitanen;Mervi Jumppanen

  • Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial

    Heikki Joensuu;Petri Bono;Vesa Kataja;Tuomo Alanko

  • Trastuzumab emtansine: mechanisms of action and drug resistance

    Mark Barok;Heikki Joensuu;Jorma Isola

  • Molecular cytogenetics of primary breast cancer by CGH.

    Mika Tirkkonen;Minna Tanner;Ritva Karhu;Anne Kallioniemi

  • Amplification and deletion of topoisomerase IIα associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

    Tero A.H. Järvinen;Minna Tanner;Virpi Rantanen;Maarit Bärlund

  • Genetic Heterogeneity and Clonal Evolution Underlying Development of Asynchronous Metastasis in Human Breast Cancer

    Tuula Kuukasjärvi;Ritva Karhu;Minna Tanner;Marketta Kähkönen

  • Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

    Olli-P. Kallioniemi;Kaija Holli;Tapio Visakorpi;Timo Koivula

  • Association of Overexpression of Tumor Suppressor Protien p53 With Rapid Cell Proliferation and Poor Prognosis in Node-Negative Breast Cancer Patients

    Jorma Isola;Tapio Visakorpi;Kaija Holli;Olli-P. Kallioniemi

  • Chromogenic in Situ Hybridization: A Practical Alternative for Fluorescence in Situ Hybridization to Detect HER-2/neu Oncogene Amplification in Archival Breast Cancer Samples

    Minna Tanner;David Gancberg;Angelo Di Leo;Denis Larsimont

  • Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.

    T Kuukasjärvi;J Kononen;H Helin;K Holli

Frequent Co-Authors

Minna Tanner
Minna Tanner Tampere University
Heikki Joensuu
Heikki Joensuu University of Helsinki
Tapio Visakorpi
Tapio Visakorpi Tampere University
Åke Borg
Åke Borg Lund University
Vesa Kataja
Vesa Kataja University of Eastern Finland
Ritva Karhu
Ritva Karhu Tampere University
Teuvo L.J. Tammela
Teuvo L.J. Tammela Tampere University
Anne Kallioniemi
Anne Kallioniemi Tampere University
Klaus Elenius
Klaus Elenius University of Turku
Pentti Tuohimaa
Pentti Tuohimaa Tampere University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a career in medicine but want a flexible or alternative entry point, there are many online degree options that can help you get started. For registered nurses aiming to advance their qualifications without breaking the bank, the cheapest rn to bsn online programs allow working professionals to increase their credentials at an affordable rate.

Those without a nursing background can look for direct entry msn programs, which offer a fast-track into advanced nursing roles for non-nurses who hold a bachelor’s degree in another field. For students who want to get into nursing with fewer hurdles, consider exploring direct admit nursing programs that simplify the admission process and potentially reduce competition.

Not all healthcare careers require a clinical degree. Administrative and support roles—such as medical billing and coding—can be pursued through flexible online education. Look for online medical billing and coding with financial aid to find accredited schools offering accessible programs with financial assistance options.

Best Scientists Citing Jorma Isola

Trending Scientists

Recently Published Articles